Osprey’s mission is to prevent the high incidence of contrast-induced acute kidney injury (AKI) in cath lab patients. By decreasing the amount of contrast dye injected into patients without affecting image quality, our proprietary technologies allow uncompromised procedural efficiency and effectiveness, with significant AKI risk reduction.